David C Paul
CIK 1555391 · View on SEC EDGAR ↗
First SEC filing: Aug. 2, 2012 · Latest: Jan. 28, 2013
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 25, 2018 | GMED | S 10b5-1 | 748,845 | $54.70 | $40,961,822 | 0 Direct | -100.00% | Disposed | 61.3% (price as of 2026-08-19) |
| Sept. 24, 2018 | GMED | S 10b5-1 | 101,320 | $54.01 | $5,472,293 | 0 Direct | -100.00% | Disposed | 63.4% (price as of 2026-08-19) |
| Sept. 24, 2018 | GMED | S 10b5-1 | 298,647 | $54.01 | $16,129,924 | 0 Indirect | -100.00% | Disposed | 63.4% (price as of 2026-08-19) |
| Sept. 24, 2018 | GMED | S 10b5-1 | 298,647 | $54.01 | $16,129,924 | 0 Indirect | -100.00% | Disposed | 63.4% (price as of 2026-08-19) |
| Sept. 24, 2018 | GMED | S 10b5-1 | 605,871 | $54.01 | $32,723,093 | 0 Direct | -100.00% | Disposed | 63.4% (price as of 2026-08-19) |
| July 17, 2018 | GMED | S 10b5-1 | 6,841 | $52.95 | $362,231 | 605,871 Direct | -1.12% | Disposed | 66.6% (price as of 2026-08-19) |
| April 30, 2018 | GMED | S 10b5-1 | 72,938 | $51.81 | $3,778,918 | 612,712 Direct | -10.64% | Disposed | 70.3% (price as of 2026-08-19) |
| April 27, 2018 | GMED | S 10b5-1 | 29,066 | $51.78 | $1,505,037 | 685,650 Direct | -4.07% | Disposed | 70.4% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 363,284 | $51.81 | $18,821,744 | 714,716 Direct | -33.70% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 43,750 | $51.81 | $2,266,688 | 1,078,000 Direct | -3.90% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 40,625 | $51.81 | $2,104,781 | 1,078,000 Direct | -3.63% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 98,958 | $51.81 | $5,127,014 | 1,078,000 Direct | -8.41% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 60,000 | $51.81 | $3,108,600 | 1,078,000 Direct | -5.27% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 48,000 | $51.81 | $2,486,880 | 1,078,000 Direct | -4.26% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 15,000 | $51.81 | $777,150 | 1,078,000 Direct | -1.37% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 18,461 | $51.81 | $956,464 | 1,078,000 Direct | -1.68% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 18,461 | $51.81 | $956,464 | 1,078,000 Direct | -1.68% | Disposed | 70.3% (price as of 2026-08-19) |
| April 26, 2018 | GMED | S 10b5-1 | 18,461 | $51.81 | $956,464 | 1,078,000 Direct | -1.68% | Disposed | 70.3% (price as of 2026-08-19) |
| March 19, 2015 | GMED | S 10b5-1 | 494,921 | $25.00 | $12,373,025 | 1,078,000 Direct | -31.47% | Disposed | 253.0% (price as of 2026-08-19) |
| March 18, 2015 | GMED | S 10b5-1 | 1,427,079 | $25.00 | $35,676,975 | 1,572,921 Direct | -47.57% | Disposed | 253.0% (price as of 2026-08-19) |
| Aug. 8, 2012 | GMED | S | 3,039,385 | $11.16 | $33,919,537 | 0 Direct | -100.00% | Disposed | 690.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (100,000) | $94.15 | Jan. 21, 2036 | 100,000 | Acquired |
| Dec. 8, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (34,375) | $25.52 | Jan. 25, 2026 | 34,375 | Disposed |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (75,000) | $92.42 | Jan. 23, 2035 | 75,000 | Acquired |
| Nov. 15, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (26,042) | $24.10 | Jan. 20, 2025 | 26,042 | Disposed |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (75,000) | $53.75 | Jan. 26, 2034 | 75,000 | Acquired |
| Dec. 5, 2023 | GMED | Class B Common Stock | Class A Common Stock (171,100) | — | — | 171,100 | Acquired |
| Dec. 5, 2023 | GMED | Class B Common Stock | Class A Common Stock (171,100) | — | — | 171,100 | Acquired |
| Dec. 5, 2023 | GMED | Class B Common Stock | Class A Common Stock (342,200) | — | — | 342,200 | Disposed |
| Jan. 26, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (75,000) | $75.18 | Jan. 26, 2033 | 75,000 | Acquired |
| Jan. 27, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (75,000) | $63.68 | Jan. 27, 2032 | 75,000 | Acquired |
| Jan. 14, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (100,000) | $65.05 | Jan. 14, 2031 | 100,000 | Acquired |
| Jan. 22, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (100,000) | $53.27 | Jan. 22, 2030 | 100,000 | Acquired |
| Jan. 22, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (100,000) | $43.58 | Jan. 22, 2029 | 100,000 | Acquired |
| Sept. 25, 2018 | GMED | Class B Common Stock [F7] | Class A Common Stock (748,845) | — | — | 748,845 | Disposed |
| Sept. 24, 2018 | GMED | Class B Common Stock [F7] | Class A Common Stock (101,320) | — | — | 101,320 | Disposed |
| Sept. 24, 2018 | GMED | Class B Common Stock [F7] | Class A Common Stock (298,647) | — | — | 298,647 | Disposed |
| Sept. 24, 2018 | GMED | Class B Common Stock [F7] | Class A Common Stock (298,647) | — | — | 298,647 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (43,750) | $26.27 | Jan. 30, 2027 | 43,750 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (40,625) | $25.52 | Jan. 25, 2026 | 40,625 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (98,958) | $24.10 | Jan. 20, 2025 | 98,958 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (60,000) | $23.95 | Jan. 23, 2024 | 60,000 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (48,000) | $13.04 | Jan. 24, 2023 | 48,000 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $15.34 | Aug. 29, 2022 | 15,000 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (18,461) | $10.66 | Oct. 27, 2021 | 18,461 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (18,461) | $11.86 | June 16, 2020 | 18,461 | Disposed |
| April 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (18,461) | $4.88 | Aug. 6, 2019 | 18,461 | Disposed |
| Jan. 22, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (100,000) | $43.77 | Jan. 22, 2028 | 100,000 | Acquired |
| Jan. 30, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (150,000) | $26.27 | Jan. 30, 2027 | 150,000 | Acquired |
| Jan. 25, 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (75,000) | $25.52 | Jan. 25, 2026 | 75,000 | Acquired |
| Jan. 20, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (125,000) | $24.10 | Jan. 20, 2025 | 125,000 | Acquired |
| Jan. 20, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (125,000) | $24.10 | Jan. 20, 2025 | 125,000 | Acquired |
| April 15, 2014 | GMED | Class B Common Stock [F10] | Class A Common Stock (3,000,000) | — | — | 3,000,000 | Disposed |
| April 15, 2014 | GMED | Class B Common Stock [F10] | Class A Common Stock (3,000,000) | — | — | 3,000,000 | Disposed |
| March 12, 2014 | GMED | Class B Common Stock [F10] | Class A Common Stock (500,000) | — | — | 500,000 | Disposed |
| March 12, 2014 | GMED | Class B Common Stock [F10] | Class A Common Stock (500,000) | — | — | 500,000 | Disposed |
| Jan. 23, 2014 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (60,000) | $23.95 | Jan. 23, 2024 | 60,000 | Acquired |
| April 22, 2013 | GMED | Class B Common Stock [F1] | Class A Common Stock (1,562,573) | — | — | 1,562,573 | Acquired |
| April 22, 2013 | GMED | Class B Common Stock [F1] | Class A Common Stock (821,063) | — | — | 821,063 | Acquired |
| April 22, 2013 | GMED | Class B Common Stock [F1] | Class A Common Stock (2,383,636) | — | — | 2,383,636 | Disposed |
| Jan. 24, 2013 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (48,000) | $13.04 | Jan. 24, 2023 | 48,000 | Acquired |
| Aug. 29, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $15.34 | Aug. 29, 2022 | 15,000 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock [F3] | Class A Common Stock [F3] (18,461) | $10.66 | Oct. 27, 2021 | 18,461 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) [F3] | Class A Common Stock [F3] (18,461) | $11.87 | June 16, 2020 | 18,461 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) [F3] | Class A Common Stock [F3] (18,461) | $4.88 | Aug. 6, 2019 | 18,461 | Acquired |
| Aug. 8, 2012 | GMED | Class B Common Stock [F2] | Class A Common Stock (3,039,385) | — | — | 3,039,385 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 2, 2012 | GMED | Class B Common Stock [F1]→ Class A Common Stock | — | Direct |
| Aug. 2, 2012 | GMED | Class B Common Stock [F1]→ Class A Common Stock | — | Indirect |
| Aug. 2, 2012 | GMED | Stock Option (Right to Buy Class C Common Stock) [F2]→ Class C Common Stock [F2] | — | Direct |
| Aug. 2, 2012 | GMED | Stock Option (Right to Buy Class C Common Stock) [F2]→ Class C Common Stock [F2] | — | Direct |
| Aug. 2, 2012 | GMED | Stock Option (Right to Buy Class C Common Stock) [F2]→ Class C Common Stock [F2] | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
GMED
Chairman of the Board of Directors and Executive Chairman| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $469,388 | $100,000 | — | — | $1,018,980 | — | $34,680 | $4,305,179 |
| 2024 | $457,419 | — | — | $1,573,332 | $999,000 | — | $30,049 | $3,059,800 |
| 2023 | $448,506 | — | — | $2,015,952 | $726,109 | — | $31,129 | $3,221,696 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.